These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1717034)

  • 1. Review of hepatitis C in Japan.
    Kiyosawa K; Furuta S
    J Gastroenterol Hepatol; 1991; 6(4):383-91. PubMed ID: 1717034
    [No Abstract]   [Full Text] [Related]  

  • 2. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic posttransfusion non-A, non-B hepatitis and autoimmune chronic active hepatitis-aspects on treatment, prognosis and relation to hepatitis C virus.
    Schvarcz R
    Scand J Infect Dis Suppl; 1991; 79():1-48. PubMed ID: 1658923
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current aspects of hepatitis C].
    Henry JP; Hayard P; Hayani A; Ligny G
    Rev Med Brux; 1994; 15(4):211-5. PubMed ID: 7524123
    [No Abstract]   [Full Text] [Related]  

  • 5. HCV transmission after receiving anti-c100-negative blood units.
    Inaba S; Fukuda M; Okochi K; Irita Y; Tokunaga K; Kiyokawa H; Maeda Y
    Lancet; 1991 Jun; 337(8753):1354. PubMed ID: 1709435
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C infection in patients with hemophilia: results of a national survey. Canadian Hemophilia Clinic Directors Group.
    Blanchette V; Walker I; Gill P; Adams M; Roberts R; Inwood M
    Transfus Med Rev; 1994 Jul; 8(3):210-7. PubMed ID: 8081082
    [No Abstract]   [Full Text] [Related]  

  • 7. Sporadic vs. posttransfusion hepatitis C: why the differences?
    Achord JL
    Gastroenterology; 1991 Oct; 101(4):1133-4. PubMed ID: 1716237
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing chronic hepatitis C virus infection.
    Lau JY; Davis GL
    BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiological and clinical significance of HCV antibody--future problems].
    Nishioka K
    Nihon Rinsho; 1991 Feb; 49(2):267-72. PubMed ID: 1849181
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of hepatitis C virus among non-A, non-B-related chronic liver disease in Egypt.
    el-Zayadi A; Selim O; Rafik M; el-Haddad S
    J Hepatol; 1992 Mar; 14(2-3):416-7. PubMed ID: 1380030
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of hepatitis C antibodies in patient groups in Egypt.
    Hassan NF
    Trans R Soc Trop Med Hyg; 1993; 87(6):638. PubMed ID: 7507607
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b.
    Genesca J; Esteban JI; Quer J; Viladomiu LL; Gonzalez A; Esteban R; Guardia J
    Gut; 1993; 34(2 Suppl):S62-3. PubMed ID: 7686120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of hepatitis C virus infection in Australia.
    Farrell GC; Weltman M; Dingley J; Lin R
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():32-6. PubMed ID: 7689506
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus in patients with acute and chronic liver disease.
    Mehta SK; Singh V; Bhasin DK; Kumar YR; Kochhar R
    Indian J Gastroenterol; 1992 Jul; 11(3):146. PubMed ID: 1380490
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 17. Three cases of posttransfusion hepatitis C treated with interferon-alpha. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy.
    Hagiwara H; Hayashi N; Kasahara A; Mita E; Takehara T; Fusamoto H; Kamada T
    Dig Dis Sci; 1992 Apr; 37(4):631-4. PubMed ID: 1312923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus.
    Tassopoulos NC; Hatzakis AE; Papatheodoridis GV; Karvountzis G; Troonen H; Lennartz L
    J Hepatol; 1994 Feb; 20(2):305-6. PubMed ID: 7516362
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HCV reactivity in dialysis patients: discrepancies between first and second generation tests.
    Beccari M; Sorgato G; Rizzolo L; Veneroni G
    Nephron; 1993; 63(2):238. PubMed ID: 7680775
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sashima epidemic hepatitis: epidemiological feature and anti-HCV status].
    Wakayama Y; Aramaki T
    Nihon Rinsho; 1991 Feb; 49(2):397-401. PubMed ID: 1849199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.